Paysign Dividends and Buybacks

Dividend criteria checks 0/6

Paysign does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-0.06%

Buyback Yield

Total Shareholder Yield	-0.06%
Future Dividend Yield	n/a
Dividend Growth	n/a
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Payout ratio	n/a

Recent dividend and buyback updates

No updates

Recent updates

Paysign, Inc. Just Beat EPS By 100%: Here's What Analysts Think Will Happen Next

Nov 16

Paysign: Gaining Traction In The Patient Affordability Space Into 2026 (Hold)

Oct 01

Paysign, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 09

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Nov 20

Rapid Growth In Patient Affordability Market Fuels Optimism Despite Looming Margin Pressures

Sep 26 The expansion into the patient affordability segment and significant client growth, like AstraZeneca, indicates a promising area for revenue and earnings increases.

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

Sep 07

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 02

Paysign: Expect Rapid Growth In Its Pharma Business

Jun 30

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Apr 26

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Mar 29

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Jan 25

The Recovery At PaySign Has Legs

Aug 30

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Aug 13

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if PAYS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PAYS's dividend payments have been increasing.

Dividend Yield vs Market

Paysign Dividend Yield vs Market

How does PAYS dividend yield compare to the market?
Segment	Dividend Yield
Company (PAYS)	n/a
Market Bottom 25% (US)	1.4%
Market Top 25% (US)	4.4%
Industry Average (Diversified Financial)	1.0%
Analyst forecast (PAYS) (up to 3 years)	n/a

Notable Dividend: Unable to evaluate PAYS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PAYS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate PAYS's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as PAYS has not reported any payouts.

Discover strong dividend paying companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/01/08 16:54
End of Day Share Price	2026/01/08 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Paysign, Inc. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Gary Prestopino	Barrington Research Associates, Inc.
Austin Moldow	Canaccord Genuity
Peter Heckmann	D.A. Davidson & Co.

Paysign Dividends and Buybacks

Dividend criteria checks 0/6

Key information

Recent dividend and buyback updates

Recent updates

Insufficient new directors

Consensus EPS estimates increase by 15%

Paysign, Inc. Just Beat EPS By 100%: Here's What Analysts Think Will Happen Next

Third quarter 2025 earnings: EPS and revenues exceed analyst expectations

Paysign, Inc. Updates Earnings Guidance for the Full Year 2025

Investor sentiment deteriorates as stock falls 16%

Paysign: Gaining Traction In The Patient Affordability Space Into 2026 (Hold)

Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

Paysign, Inc. Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

Paysign, Inc. Announces Board Changes

Paysign, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Second quarter 2025 earnings released

Co-Founder exercised options and sold US$440k worth of stock

Paysign, Inc. Provides Earnings Guidance for the Third Quarter and Updates Earnings Guidance for Full Year 2025

Price target increased by 11% to US$8.40

Investor sentiment improves as stock rises 16%

Independent Director recently bought US$50k worth of stock

Price target increased by 7.5% to US$7.15

Non-Executive Independent Director exercised options to buy US$87k worth of stock.

New minor risk - Share price stability

Investor sentiment improves as stock rises 23%

Consensus EPS estimates have been upgraded.

Price target increased by 9.9% to US$6.65

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Paysign, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2025

Investor sentiment improves as stock rises 18%

Paysign, Inc.'s (NASDAQ:PAYS) 28% Price Boost Is Out Of Tune With Earnings

Consensus EPS estimates fall from profit to US$0.012 loss, revenue upgraded

Price target decreased by 9.0% to US$6.05

Paysign, Inc., Annual General Meeting, May 07, 2025

Paysign, Inc. (NasdaqCM:PAYS) acquired Gamma Innovation LLC.

Full year 2024 earnings: EPS exceeds analyst expectations

Paysign, Inc. Provides Earnings Guidance for the Fist Quarter and Full Year 2025

Paysign, Inc. Appoints Michael Ngo as Chief Innovation Officer

CFO & Treasurer exercised options and sold US$69k worth of stock

Paysign, Inc.'s (NASDAQ:PAYS) Share Price Not Quite Adding Up

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 15%

Here's Why Paysign (NASDAQ:PAYS) Has Caught The Eye Of Investors

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Investor sentiment deteriorates as stock falls 15%

Chief Payments Officer & Director recently sold US$100k worth of stock

Consensus EPS estimates increase by 26%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Paysign, Inc. Reiterates Earnings Guidance for the Year 2024

Rapid Growth In Patient Affordability Market Fuels Optimism Despite Looming Margin Pressures

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

New minor risk - Insider selling

Consensus EPS estimates fall by 22%, revenue upgraded

Price target increased by 7.5% to US$6.58

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment improves as stock rises 34%

Paysign: Expect Rapid Growth In Its Pharma Business

Independent Director exercised options to buy US$85k worth of stock.

Consensus EPS estimates increase by 33%

Price target increased by 8.9% to US$6.13

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 30%, revenue upgraded

PaySign, Inc., Annual General Meeting, May 03, 2024

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Price target increased by 14% to US$5.25

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of the Common Stock of Paysign, Inc

Consensus EPS estimates increase by 25%

New major risk - Earnings quality

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Market cap size